First National Bank of South Miami’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
MCM
FCBT
First National Bank of South Miami's XPH Position: Q1 2023 in Review
First National Bank of South Miami sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2023, closing a stake of 840 shares — an estimated $34K sold.
First National Bank of South Miami first reported a position in XPH in Q4 2018 and held it in 17 quarters. The position peaked at $44K in Q4 2020. 61 funds tracked by Wall St. Rank hold XPH as of Q1 2023.
- First National Bank of South Miami reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2023 after selling out during the quarter.
- First National Bank of South Miami sold 840 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2023, an estimated $34K.
- First National Bank of South Miami first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2018 and held it in 17 quarters.
- First National Bank of South Miami's State Street SPDR S&P Pharmaceuticals ETF position peaked at $44K in Q4 2020.
- 61 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2023.
Based on First National Bank of South Miami's 13F filing for Q1 2023, filed 17 Apr 2023.